Skip to content
HowShorted

Perspective Therapeutics, Inc. short interest in 2021

In 2021, Perspective Therapeutics, Inc.'s disclosed short interest ran from 1.75% of shares outstanding on 12 Feb 2021 to 0.63% on 31 Dec 2021, a change of -1.12 percentage points. The year's high was 2.02% on 15 Mar 2021 and its low 0.63% on 31 Dec 2021, averaging 1.14% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.70 days on 13 Aug 2021. Full history: Perspective Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Perspective Therapeutics, Inc. in 2021

2021 in figures

Start of year
1.75% (12 Feb 2021)
End of year
0.63% (31 Dec 2021)
Change
-1.12 pp
High
2.02% (15 Mar 2021)
Low
0.63% (31 Dec 2021)
Average
1.14%
Highest days to cover
2.70 (13 Aug 2021)
SEC filings marked
9

Every report in 2021

Perspective Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
12 Feb 20211.75%1.00results (8-K), 10-Q filed, results (8-K)
26 Feb 20211.70%1.00
15 Mar 20212.02%1.00
31 Mar 20211.49%1.00
15 Apr 20211.88%1.79
30 Apr 20211.37%1.26
14 May 20211.28%2.02results (8-K), 10-Q filed
28 May 20210.87%1.53
15 Jun 20211.00%1.00
30 Jun 20210.89%1.24
15 Jul 20210.90%1.65
30 Jul 20210.92%1.90
13 Aug 20210.94%2.70
31 Aug 20210.72%1.16
15 Sep 20210.83%1.42
30 Sep 20211.18%2.08results (8-K), 10-K filed
15 Oct 20210.92%2.21
29 Oct 20211.00%2.46
15 Nov 20211.11%2.2510-Q filed, results (8-K)
30 Nov 20210.88%1.42
15 Dec 20210.81%1.40
31 Dec 20210.63%1.00

See also: Perspective Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.